TrialBone marrow transplantation2023

A prospective phase 2 clinical trial of a C5a complement inhibitor for acute GVHD with lower GI tract involvement.

Rohtesh S Mehta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.